About Us

Business Ethics

Strategic Projects

Initiatives

Useful Links

Members

News

02/2026
Interview with Schalk Opperman, GM/MD at Merck Croatia & Slovenia...
02/2026
Interview with Lana Kuzik Ileš, Country Manager, Bayer Croatia...

Innovative Pharmaceutical Initiative – iF!

EFPIA/iF! Code on Disclosure of Data 2016

Transparency, trust, and understanding of relationships focused on patient well-being

Transparency, trust, and understanding of relationships focused on patient well-being

Transparency, trust, and understanding of relationships focused on patient well-being. Collaboration between the pharmaceutical industry and healthcare professionals and organizations in the development of innovative medicines has changed the course of many diseases. The disclosure of payments made to healthcare professionals and organizations strengthens trust in the ethical and impartial nature of treatment-related decisions.

Published
22. April 2016.
Source
Category

Latest News

02/2026
Interview with Schalk Opperman, GM/MD at Merck Croatia & Slovenia...
02/2026
Interview with Lana Kuzik Ileš, Country Manager, Bayer Croatia...
01/2026
Interview with Javier Aracil Corma, General Manager of the AbbVie Adriatic and Hungary...
01/2026
Croatia at a crossroads – time for bold decisions in healthcare!...
02/2021
Advances in the research and development of therapeutic options witnessed in recent years...
02/2021
There are significant differences in treatment outcomes across European Union member states, and...
02/2021
Thanks to new knowledge and the discovery of new medicines that had previously...
Scroll to Top

About Us

Business Ethics

Strategic Projects

Initiatives

Useful Links

Members

News

02/2026
Interview with Schalk Opperman, GM/MD at Merck Croatia & Slovenia...
02/2026
Interview with Lana Kuzik Ileš, Country Manager, Bayer Croatia...
Start typing to search